Avanos Medical (FRA:8HH) Other Stockholders Equity: €0.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8HH Avanos Medical Inc FRA:8HH
62 GF Score
Price €21.20
GF Value €16.45
! 5 Warning Signs
View Full Analysis

What is Avanos Medical Other Stockholders Equity?

Avanos Medical FRA:8HH -0.93% 62 Other Stockholders Equity is €0.4 Mil as of Mar. 2026. GuruFocus rates FRA:8HH with a GF Score™ of 62/100 and a GF Value™ of €16.45. The stock has 5 warning signs investors should review.

Avanos Medical's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €0.4 Mil.

Avanos Medical's quarterly Other Stockholders Equity increased from Sep. 2025 (€-0.0 Mil) to Dec. 2025 (€0.0 Mil) and increased from Dec. 2025 (€0.0 Mil) to Mar. 2026 (€0.4 Mil).

Avanos Medical's annual Other Stockholders Equity declined from Dec. 2023 (€-0.0 Mil) to Dec. 2024 (€-0.0 Mil) but then increased from Dec. 2024 (€-0.0 Mil) to Dec. 2025 (€0.0 Mil).

Avanos Medical Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Avanos Medical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avanos Medical Other Stockholders Equity Chart

Avanos Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -0.00 0.00

Avanos Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 0.43
FRA:8HH
62GF Score
Avanos Medical Inc FRA:8HH
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avanos Medical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €0.4 Mil mean?
Avanos Medical (FRA:8HH) has a Other Stockholders Equity of €0.4 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Avanos Medical and its competitors.
Is Avanos Medical's Other Stockholders Equity too high?
Avanos Medical's current Other Stockholders Equity is €0.4 Mil. Overall, Avanos Medical has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Other Stockholders Equity compare to LMRI and AORT?
Avanos Medical's Other Stockholders Equity of €0.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Avanos Medical and its competitors. Avanos Medical's current Other Stockholders Equity is €0.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Avanos Medical (FRA:8HH) has a current Other Stockholders Equity of €0.4 Mil. The stock's GF Value™ is €16.45, compared to a current price of €21.20 — trading 28.9% above its estimated fair value. The current Other Stockholders Equity is €0.4 Mil. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Avanos Medical (FRA:8HH), the current Other Stockholders Equity is €0.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avanos Medical (FRA:8HH) Overvalued in 2026?

Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued. The current stock price of €21.20 is trading 28.9% above its estimated GF Value™ of €16.45.

Key valuation signals for FRA:8HH:

  • Other Stockholders Equity: €0.4 Mil
  • GF Value™: €16.45 vs. price of €21.20 (28.9% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the FRA:8HH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avanos Medical Business Description

Other Exchanges AVNS:USA
Address 5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score

Get the complete analysis for FRA:8HH

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.20
Price
€16.45
GF Value